Skip to content
Goldra Enterprise

The Zimbabwean Government Turns Down ‘One-Sided’ American Healthcare Assistance Agreement Due to Information Concerns

Health funding image
The offered American financial assistance would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a substantial US health deal worth $367m (£272m) spanning five years due to Washington's request for confidential biological samples.

This rejection became public after a official document dated December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".

A government representative has since stated that the US was requesting biological samples for scientific study and commercial purposes but was unwilling to share the resulting advantages from future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has urged further talks to secure a deal suitable to both sides so the country's vital HIV programme can proceed.

Broader Context

This development comes after a similar case in Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.

As per reports, 16 nations in Africa have to date signed similar agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this collaboration might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," his statement read.

"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our population should a new health crisis arise."

National Interest and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems already set up through the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with future pandemics.

"This system is designed to guarantee that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."

These objections over the US deal "are not meant as hostility towards the US," he added.

"We welcome ongoing dialogue with our American counterparts on how future collaboration could be structured in a manner that respects the sovereignty and dignity of each country."

Health Experts Response

A leading public health body stated it understood the government's concerns, but recommended that negotiations must proceed since much of the country's HIV programmes were funded by international support.

"In cases where technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group commented.

The halted deal underscores the continuing debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.

MC
Written by

Michelle Clark

Elara Vance is a business strategist with over 15 years of experience helping UK enterprises scale and innovate in competitive markets.

Goldra Enterprise

Type to search articles.